Search Results - "Timar, Botond"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    The effect of biological heterogeneity on R-CHOP treatment outcome in diffuse large B-cell lymphoma across five international regions.

    Authors: Carr, Robert Ozdag, Hilal Tekin, Nilgun et al.

    Source: Leukemia & Lymphoma. May2017, Vol. 58 Issue 5, p1178-1183. 6p.

    HTML Full Text PDF Full Text
    Save to List
  2. 2

    Myelofibrosis progression grading based on type I and type III collagen and fibrillin 1 expression boosted by whole slide image analysis.

    Authors: Szekely, Tamas Wichmann, Barna Maros, Mate E et al.

    Source: Histopathology. Mar2023, Vol. 82 Issue 4, p622-632. 11p.

    HTML Full Text PDF Full Text
    Save to List
  3. 3

    Enumeration of CD34+ blasts by immunohistochemistry in bone marrow biopsies from MDS patients may have significant impact on final WHO classification.

    Authors: Saft, Leonie Timar, Botond Porwit, Anna

    Source: Journal of hematopathology Jun2020; Vol. 13 (2).

    Journal Info: Publisher: Springer Nature ISSN: 1868-9256

    HTML Full Text PDF Full Text
    Save to List
  4. 4

    Long term follow-up of refractory/relapsed hairy cell leukaemia patients treated with low-dose vemurafenib between 2013 and 2022 at the Department of Internal Medicine and Oncology, Semmelweis University.

    Authors: Ferenczi K Nagy ZF Istenes I et al.

    Source: Pathology oncology research : POR [Pathol Oncol Res] 2023 Nov 08; Vol. 29, pp. 1611378. Date of Electronic Publication: 2023 Nov 08 (Print Publication: 2023).

    Publication Type: Journal Article

    Journal Info: Publisher: Frontiers Media S. A Country of Publication: Switzerland NLM ID: 9706087 Publication Model: eCollection Cited Medium: Internet ISSN: 1532-2807 (Electronic) Linking ISSN: 12194956 NLM ISO Abbreviation: Pathol Oncol Res Subsets: MEDLINE

    PDF Full Text
    Save to List

Search Tools: